T. Rowe Price Associates’s Aimmune Therapeutics AIMT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $88.1M | Buy |
|
|||||
|
2020
Q1 | $74.9M | Sell |
|
|||||
|
2019
Q4 | $188M | Buy |
|
|||||
|
2019
Q3 | $111M | Buy |
|
|||||
|
2019
Q2 | $109M | Buy |
|
|||||
|
2019
Q1 | $105M | Sell |
|
|||||
|
2018
Q4 | $114M | Buy |
|
|||||
|
2018
Q3 | $128M | Buy |
|
|||||
|
2018
Q2 | $125M | Buy |
|
|||||
|
2018
Q1 | $143M | Buy |
|
|||||
|
2017
Q4 | $95.1M | Buy |
|
|||||
|
2017
Q3 | $34.2M | Sell |
|
|||||
|
2017
Q2 | $28.7M | Buy |
|
|||||
|
2017
Q1 | $25.4M | Buy |
|
|||||
|
2016
Q4 | $22.2M | Sell |
|
|||||
|
2016
Q3 | $17.4M | Buy |
|
|||||
|
2016
Q2 | $6.54M | Buy |
|
|||||
|
2016
Q1 | $6.62M | Sell |
|
|||||
|
2015
Q4 | $9.05M | Buy |
|
|||||
|
2015
Q3 | $11.2M | Buy |
|